$0.253
-0.018 (-7.17%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MREO Prediction & Forecast by Similar Chart Analysis
Alphio's MREO stock price prediction model matches the current Mereo BioPharma Group PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.25 (+0.56%). The 1-week path is $0.26 (+1.55%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Mereo BioPharma Group PLC Stock?
Mereo BioPharma is not a good buy right now. The current price is $0.2525, and the stock has experienced a significant decline of 85.73% over the past year. Additionally, the RSI is at a very low 15.36, indicating oversold conditions, but this could signal further downside risk rather than a buying opportunity. The downgrade from JP Morgan highlights regulatory uncertainties that could hinder future performance, making it a risky investment at this time.
MREO stock price ended at $0.25 on Friday, after losing -7.17%
Mereo BioPharma Group PLC (MREO) last closed at $0.2525, losing -7.17%. These facts feed the 1-day and 1-week MREO price prediction above.
Forecast Drivers
Mereo BioPharma Group PLC (MREO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MREO, ranked by similarity.
Seasonality analysis for MREO
Historically the probability of a positive August return for MREO is 34.92%. January offers the highest probability of a positive month at 55.74%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MREO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.30 | $1.58 | $1.59 | +525.63% |
| Sep 2026 | $1.70 | $1.89 | $1.97 | +648.11% |
| Oct 2026 | $1.65 | $1.71 | $1.84 | +577.96% |
| Nov 2026 | $1.69 | $1.75 | $1.92 | +591.61% |
| Dec 2026 | $1.80 | $1.89 | $1.93 | +649.29% |
In 2026, Mereo BioPharma Group PLC (MREO) is projected to range from $1.30 to $1.97.
Mereo BioPharma Group PLC 2026 monthly forecast
In Aug 2026, Mereo BioPharma Group PLC is projected to average $1.58, with a low of $1.30 and high of $1.59.
In Sep 2026, Mereo BioPharma Group PLC is projected to average $1.89, with a low of $1.70 and high of $1.97.
In Oct 2026, Mereo BioPharma Group PLC is projected to average $1.71, with a low of $1.65 and high of $1.84.
In Nov 2026, Mereo BioPharma Group PLC is projected to average $1.75, with a low of $1.69 and high of $1.92.
In Dec 2026, Mereo BioPharma Group PLC is projected to average $1.89, with a low of $1.80 and high of $1.93.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.